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Abstract
Background: Family caregivers of dementia patients are at increased risk of developing depression or anxiety. A multi-
component program designed to mobilize support of family networks demonstrated effectiveness in decreasing depressive
symptoms in caregivers. However, the impact of an intervention consisting solely of family meetings on depression and
anxiety has not yet been evaluated. This study examines the preventive effects of family meetings for primary caregivers of
community-dwelling dementia patients.
Methods: A randomized multicenter trial was conducted among 192 primary caregivers of community dwelling dementia
patients. Caregivers did not meet the diagnostic criteria for depressive or anxiety disorder at baseline. Participants were
randomized to the family meetings intervention (n = 96) or usual care (n = 96) condition. The intervention consisted of two
individual sessions and four family meetings which occurred once every 2 to 3 months for a year. Outcome measures after
12 months were the incidence of a clinical depressive or anxiety disorder and change in depressive and anxiety symptoms
(primary outcomes), caregiver burden and quality of life (secondary outcomes). Intention-to-treat as well as per protocol
analyses were performed.
Results: A substantial number of caregivers (72/192) developed a depressive or anxiety disorder within 12 months. The
intervention was not superior to usual care either in reducing the risk of disorder onset (adjusted IRR 0.98; 95% CI 0.69 to
1.38) or in reducing depressive (randomization-by-time interaction coefficient =21.40; 95% CI 23.91 to 1.10) or anxiety
symptoms (randomization-by-time interaction coefficient =20.55; 95% CI 21.59 to 0.49). The intervention did not reduce
caregiver burden or their health related quality of life.
Conclusion: This study did not demonstrate preventive effects of family meetings on the mental health of family caregivers.
Further research should determine whether this intervention might be more beneficial if provided in a more concentrated
dose, when applied for therapeutic purposes or targeted towards subgroups of caregivers.
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Introduction
Caring for a family member with dementia can be a stressful
experience and has been associated with negative outcomes such
as depression and anxiety. According to one study, almost half of
the caregivers developed depression diagnosed according to
research diagnostic criteria within one year after the initial
assessment [1,2]. Previously, we estimated that spouses of patients
with dementia have a fourfold higher risk of depression than
spouses of non-demented persons [3]. The incidence of anxiety
among dementia caregivers has received less attention, but a
recent review showed that clinically significant anxiety affects
about a quarter of caregivers of people with dementia and was
more common than in matched controls [4].
Given the large number of caregivers who may suffer from
clinical depression or anxiety, providing adequate treatment for all
of them would place a heavy burden on health care resources and
might not be feasible. Alternative strategies, such as prevention,
can potentially be a more cost effective approach. Preventive
interventions have proven to be effective in reducing the incidence
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of anxiety and depressive disorders in non-caregiving populations
[5–8] and are most likely to be effective when targeted at those
with a high a priori risk of developing the disorder [9,10]. This can
be achieved by focusing on people exposed to established risk
factors for a disorder (selective prevention), as is the case in the
population of dementia caregivers. Thus, the literature suggests
that a preventive intervention might be an effective strategy for
this target group.
Over the last decades, various strategies for supporting
caregivers have been developed. Systematic reviews and meta-
analyses indicate mixed results with respect to the effectiveness of
these interventions on caregiver mood or burden [11,12].
Information and support alone may be helpful, but appears to
address the psychological needs of caregivers only marginally
[13,14]. Programs that demonstrate beneficial effects involve both
patients and their families, are more intensive and are designed to
meet each caregiver’s individual needs [13,15]. Results of the
NYU Caregiver Intervention (NYUCI), a multi-component
intervention that included family counseling, individual counseling
sessions, support group participation and continuous availability of
ad hoc counseling have demonstrated that counseling and support
interventions designed to mobilize support of naturally existing
family networks, appear to be effective in reducing depressive
symptoms in caregivers [16,17] and in delaying nursing home
placement of the dementia patient [18,19]. However, it is unclear
whether family meetings alone have preventive effects. Therefore,
in this study we investigated whether structured family meetings
are more effective than usual care in the prevention of depression
or anxiety disorders in caregivers. We also evaluated the effects on
the severity of depressive and anxiety symptoms, caregiver burden
and quality of life of the caregiver.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Participants
Caregivers and patients were recruited through memory clinics
(n = 91), services delivering case management (n = 79), general
practices, home care settings and meeting centers for people with
dementia and their caregivers (n = 22) in the Netherlands.
Caregivers were eligible if they were the primary family caregiver
of a community dwelling relative with a clinical diagnosis of
dementia and had at least one other family member or friend
available to participate in the family meetings. If there was more
than one family caregiver caring for the patient, the primary
caregiver was identified as the person who coordinated the caring
process, usually the person who spends most hours on caregiving
tasks. Caregivers were excluded when 1) they met the criteria for a
clinical depressive or anxiety disorder as measured with the Mini
International Neuropsychiatric Interview (MINI) [20], 2) the
patient was scheduled to move into a nursing home, 3) they
presented with severe somatic or psychiatric co-morbidity which
would significantly impair cooperation with the study, and 4) they
had insufficient proficiency in the Dutch language thus hampering
adequate participation in meetings and interviews.
Ethics
The Medical Ethics Committee of the VU University Medical
Center approved the study protocol. Written informed consent
was obtained from all participants.
Intervention
Caregivers randomized to the intervention group were invited
to participate in six in-person counseling sessions: one individual
preparation session, followed by four structured meetings that
included their relatives and/or friends (family meetings), and one
additional individual evaluation session. The family meetings were
held once every 2 to 3 months in the year following enrollment in
the program based on pilot experience with some families prior to
the study.
Preparation meeting. The first individual session was aimed
to prepare the caregiver for the family meetings and to propose the
idea of seeking help from family and friends.
Family meetings. The aim was to offer psycho-education,
teach problem solving techniques and mobilize the existing family
networks of the patient and primary caregiver in order to improve
emotional and instrumental support. The content of the sessions
was guided by the needs of the caregiver. During the first family
meeting the purpose of the meetings, the protocol, ground rules
and the counselor’s role were explained to the caregiver and the
family. Relevant issues were identified (e.g. management of patient
behavior problems, coping with feelings of guilt) and the counselor
motivated the family to form ideas to help the caregiver and to
delegate tasks. The follow up meetings reviewed the previous
session, previous commitments and the progress of tasks. Ad hoc
telephone counseling from the same counselor was available to
caregivers and their families beyond the scheduled sessions.
Evaluation session. After the final family session, an
individual session was held to evaluate the caregiver’s satisfaction
with the intervention program and to start additional support
when requested.
The counselors who led the family meetings had an advanced
degree in nursing, social work, psychology or an allied profession
and were trained prior to the study by the research team. One
counselor was assigned to each caregiver to establish an ongoing
relationship with a person familiar with the situation. The family
meetings were audio taped for supervision and reviewed randomly
and on request to give feedback to the counselors. To encourage
and evaluate protocol adherence, after a family session, the
counselor filled in a standardized form and was contacted by the
researcher (KJ) individually to monitor and discuss difficulties. For
more detail about the intervention, see Joling et al. 2008 [21].
Usual care. Caregivers randomized to the control condition
received care as usual. Usual care in the Netherlands may consist
of a range of health care and welfare services and can differ across
participants. However, family meetings are rarely organized and
never in a structured way or with follow-up sessions. They also
tend to focus on providing clinical information and not on
increasing family support and relieving the caregiver. Usual care
participants were free to use all types of care, including
community-based mental health services or support resources
other than family meetings at any time throughout the 12 months
follow-up, therefore reflecting standard care. The participants’ use
of health care services and their participation in family meetings
was recorded.
Objective
To determine whether a family meetings intervention prevents
the development of anxiety and depressive disorders superior to
usual care. The design of this study has been described in detail
elsewhere [21].
Primary & secondary outcomes
Primary outcomes. Major depressive disorder and anxiety
disorders were assessed every 3 months after enrollment with the
Preventive Effects of Family Meetings
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Mini International Neuropsychiatric Interview (MINI) [20]. The
MINI is a short, structured diagnostic interview for DSM-IV
mental disorders and can be used for psychiatric evaluation and
outcome tracking. The severity of symptoms of depression was
measured every 6 months with the Center for Epidemiologic
Studies Depression Scale (CES-D) and with the Hospital Anxiety
and Depression Scale- Anxiety subscale (HADS-A) for anxiety.
The CES-D consists of 20 items, with a total score ranging
between 0 and 60. Higher scores indicate greater psychological
distress, and scores of 16 and above indicate the presence of
clinically significant depression [22]. The HADS-A consists of 7
items, with total scores ranging between 0 and 21. A score of 8 or
higher suggests the presence of clinically significant anxiety
[23,24].
Secondary outcomes. Secondary outcomes were assessed
every 6 months and included: five dimensions of caregiver burden
(disrupted time, financial problems, lack of family support, health
problems, and caregiver’s self-esteem) measured with the Caregiver
Reaction Assessment (CRA) [25], and health-related quality of life
using the Short Form-12 item questionnaire (SF-12) [26].
Sample size
The sample size calculation was based on the expected effects of
the intervention on the main outcome measures, incidence of a
depression or anxiety disorder. The yearly incidence of disorders
among caregivers at risk was estimated at 30% [2]. The trial was
powered to detect a 20% decrease in the incidence. We calculated
that 73 participants per group would be needed, assuming a 2-
sided test, an alpha of 0.05 and a power of 80%. With a drop out
of 20%, at least 182 participants would be needed.
Randomization & blinding
After informed consent and baseline measurement, dyads of
patients and their primary family caregiver were randomized by
an independent researcher, stratified by recruitment center, in
blocks of four to either usual care or the family meetings
intervention. The interviewers who measured the outcomes were
blinded to randomisation status. The participants and the
counselors conducting the family meetings were aware of the
intervention assigned.
Statistical analyses
We investigated if randomization had resulted in a balanced
distribution of prognostically important variables across the
conditions. In addition, we compared the baseline characteristics
of dropouts and those who completed the 12-month measurement
by performing logistic regression analysis. Data were primarily
analyzed on the basis of the intention-to-treat principle (ITT), which
means that all participants were analyzed in the group to which they
were randomized. This analysis requires imputation of missing
observations. The missing values on the outcomes measures were
imputed using multiple imputation by chained equations. In
contrast to other imputation techniques, this method minimally
alters variance of data, thus providing the best estimates of missing
data, at least until 50% of the data are missing [27]. To estimate to
what extent the intervention was more successful in reducing the
risk of depressive and anxiety disorders than usual care, we first
performed an unadjusted Poisson regression analysis of the clinical
depression or anxiety cumulative incidence (1= became disordered
and 0= remained disorder free over the last year) on the treatment
indicator (0= usual care, 1 = intervention). In this manner we
obtained a crude incidence rate ratio (IRR) which describes the
difference in incidence rate in the intervention relative to usual care.
The superiority of the intervention would be supported if the IRR
falls below 1 and would be significant at P,0.05, 2-tailed. Estimates
of the intervention effects on the continuous outcome measures
were obtained from linear mixed models. These take into account
the repeated measurements for each subject. The randomization
status, time of measurement and randomization-by-time interaction
were included as fixed effects in the models. Multilevel modeling
was used to analyze the repeated measurements. The models
included a random intercept for each site and a random intercept
and slope for each patient. We assessed the overall effect of the
intervention by testing the interaction between randomization and
time of measurement. To adjust for selection-bias, variables with
significant baseline differences and a significant association with
outcome (HADS-A baseline score) were incorporated as covariates
in all analyses. All analyses were performed while taking into
account the hierarchical structure of data, with caregivers nested in
recruitment sites. The models were fitted in Stata (version 11) using
the xtmixed command. Because placement and death of the patient
might affect the outcomes, the ITT analyses were replicated
removing the caregivers where the patient either died or was
institutionalized during the study. The results of the intention-to-
treat analyses were compared with the results of the per protocol
analysis. This type of analysis can assess whether protocol violations
have caused bias. In the per-protocol analyses, outcomes of the
participants who attended at least three family meetings were
compared with the outcomes of the usual care group.
Finally, we performed ancillary analyses to investigate the
possible modification of the treatment effect by caregiver gender,
dementia severity, initial depressive or anxious symptoms within
the caregivers, lack of family support, and recruitment via sites
offering intensive support resources. These effect modification
analyses were conducted to determine whether caregivers with
certain baseline characteristics would benefit (more) from family
meetings. The analyses were performed with the SPSS (version
15.0) and Stata (version 11) statistical packages.
Results
Participant flow and recruitment
Participants were recruited from November 2007 to November
2009. Of the caregivers assessed for eligibility, 192 met all
inclusion criteria and were willing to participate (Figure 1).
Reasons for exclusion were ‘patient not diagnosed with dementia’
(n = 10), ‘no other family member or friend available to participate
in the family meetings’ (n = 16), ‘insufficient command of the
Dutch language’ (n = 9), ‘patient was (scheduled to be) institution-
alized’ (n = 39), ‘caregiver had a clinical depressive or anxiety
disorder at intake’ (n = 7).
A substantial number of 410 caregivers refused to participate.
Most refusals were due to claiming a lack of need for this
intervention (n= 202). These caregivers already used other
services, said they could (still) manage on their own or did not
expect to benefit from the intervention. Other reasons for refusal
included: too burdensome (n= 85), practical reasons (n = 33),
resistance of the family or patient (n = 21), not willing to burden
their family (n = 19), difficulties with the randomized design (n= 3)
and reason unknown (n= 47). There were no significant
differences between the dyads of caregivers and patients who
declined participation and the participating dyads in gender,
caregiver-patient relation and the type of service they were
recruited from. Patients recruited from memory clinics were
younger than those recruited from casemanagement (difference in
mean=24.58, 95% CI 27.68 to 21.48, p = 0.002) and primary
care settings (difference in mean=27.04, 95% CI 211.83 to
22.26, p = 0.002)
Preventive Effects of Family Meetings
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e30936
Baseline characteristics
Table 1 presents the socio-demographic and clinical character-
istics of the caregivers and patients at baseline. Caregivers and
patients in the intervention group were significantly younger
(difference in mean patients’ age = 3.85 , 95% CI 1.372 to 6.328,
t = 3.07 with 190 df, p = 0.002 and difference in mean caregivers’
age = 3.37, 95% CI 0.447 to 6.302, t = 2.27 with 190 df, p = 0.024)
and caregivers had higher HADS-A scores (difference in
mean=21.24, 95% CI 22.219 to 20.266, t =22.51 with 188
df, p = 0.013) at baseline than participants in the usual care group.
The HADS-A baseline score was also a significant predictor of
outcome and was therefore incorporated as covariate in the
analyses.
Numbers analyzed
Follow-up data were collected for twelve months after
enrollment from 81/96 (84%) intervention and 86/96 (90%)
usual care group participants. Loss to follow-up was significantly
associated with poorer perceived physical health of the caregiver at
baseline (OR=0.959, 95% CI 0.923 to 0.996). In accordance with
the intention-to-treat principle, missing follow-up data were
imputed and all participants were included in the analyses.
Primary outcomes
Incidence of depression and anxiety. An incident
depressive or anxiety disorder occurred in 38 participants in the
intervention group and 34 participants in the usual care group
(unadjusted IRR=1.12, se = 0.23, t = 0.54, p = 0.593, 95% CI
0.74 to 1.70). Table 2 presents the results of the analyses adjusted
for the confounding effect of the HADS-A baseline score and
clustering of patients within sites. These results indicate that the
intervention did not significantly reduce the risk of developing a
depressive/anxiety disorder compared to usual care. We repeated
the analysis on the incidence of depression and anxiety separately
as distinct outcomes. Respectively 28 and 19 caregivers in the
intervention group and usual care group developed a depressive
disorder. Twenty-eight intervention caregivers and 27 usual care
caregivers developed an anxiety disorder. Comorbidity was
Figure 1. Flow diagram of the study sample.
doi:10.1371/journal.pone.0030936.g001
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present in 18 of the intervention participants and in 13 of the usual
care participants. These differences were again not significant in
the distinct analyses (Table 2).
Severity of symptoms. No significant differences on the
severity of depressive and anxiety symptoms over time were found
between the intervention and usual care group (Table 3). The
mean CES-D scores show that the level of depressive symptoms
incremented in both groups over the 12 month follow-up period.
Anxiety symptoms (HADS-A scores) increased slightly in the usual
care group and remained stable in the intervention group.
Secondary outcomes
No significant intervention effects were found on any of the
dimensions of caregiver burden and on health related quality of
life of the caregiver (Table 3).
Intervention uptake and per protocol analyses
Of those randomized to the intervention group, 91/96
participated in the preparation session, 73/96 attended 1 or 2
family meetings and 44/96 adhered (i.e. completed the prepara-
tion session plus 3 or 4 family meetings within 12 months) to the
intervention protocol. The 44 adherers did not significantly differ
on any of the baseline characteristics compared with the non-
adherers, despite that for non-adherers the patient’s number of
ADL dependencies was slightly higher (difference in
mean=20.56, 95% CI 21.11 to 20.01, t =22.04 with 93 df,
p = 0.044). Reasons for non-adherence were: resistance of family/
family conflicts (n = 11), no perceived need for (more) family
meetings (n = 10), too burdensome (n= 9), placement in a nursing
home or death of the patient (n = 7), practical considerations
(n = 5), other reasons (n = 3). Furthermore, seven caregivers
Table 1. Baseline demographic and clinical characteristics of the caregivers and patients.
Caregiver Patient
Intervention (n =96) Usual care (n =96) Intervention (n=96) Usual care (n =96)
Age, M (SD) 67.8 (9.8)* 71.2 (10.7) 72.8 (9.1)* 76.7 (8.3)
Female gender, n (%) 67 (69.8) 68 (70.8) 30 (31.3) 32 (33.3)
Spouse of the patient, n (%) 92 (95.8) 89 (92.7)
Living with patient, n (%) 93 (96.9) 91 (94.8)
Educational level, n (%)
Elementary/Lower 28 (29.2) 34 (35.4) 42 (43.8) 44 (45.8)
Secondary 37 (38.5) 30 (31.3) 30 (31.3) 28 (29.2)
Higher/University 29 (30.2) 32 (33.3) 24 (25.0) 22 (22.9)
Chronic diseases
0 (%) 32 (33.3) 28 (29.2) 25 (26.0) 26 (27.1)
1 or more (%) 63 (65.6) 68 (70.8) 70 (72.9) 70 (72.9)
CES-D (0–60), M (SD) 12.1 (7.9) 10.8 (7.1)
$16, n (%) 31 (32.3) 23 (24.0)
HADS-A (0–21), M (SD) 6.1 (3.4)* 4.8 (3.5)
$8, n (%) 32 (33.3) 23 (24.0)
CRA Disrupted time (5–25) , M (SD) 15.6 (4.0) 15.2 (4.3)
CRA Financial problems (3–15) , M (SD) 6.5 (1.8) 6.4(1.8)
CRA Lack of family support (5–25) , M (SD) 12.8 (4.0) 12.2 (3.9)
CRA Health problems (4–20) , M (SD) 10.3 (2.8) 9.9 (3.1)
CRA Caregiver’s self-esteem (7–35) , M (SD) 26.9 (3.5) 26.9 (3.7)
Can caregiver leave the patient alone?
No 13 (13.5) 8 (8.3)
Yes, but not unlimited 59 (61.5) 65 (67.7)
Yes, unlimited 23 (24.0) 23 (24.0)
ADL independencies (out of 6), M (SD) 5.1 (1.4) 5.3 (1.1)
IADL independencies (out of 7), M (SD) 2.7 (1.8) 2.6 (1.5)
MMSE (0–30), M (SD) 21.4 (4.9) 21.7 (5.6)
NPI-Q (0–36), M (SD) 8.5 (5.4) 9.5 (6.3)
Type of dementia
Alzheimer disease 54 (56.3) 56 (58.3)
Other 38 (39.6) 35 (36.5)
Type not specified/unknown 4 (4.2) 5 (5.2)
M: Mean; SD: Standard deviation; CES-D: Center for Epidemiologic Studies Depression Scale; HADS-A: Hospital Anxiety and Depression Scales; CRA: Caregiver reaction
assessment scale; (I)ADL: (Instrumental) activities of daily living; MMSE: Mini Mental State Examination; NPI-Q: Neuropsychiatric Inventory- Questionnaire.
*significant difference with usual care group (p,0.05).
doi:10.1371/journal.pone.0030936.t001
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finished the intervention, but not within 12 months after
enrollment.
Of the 73 caregivers who attended at least one family meeting,
64 completed an evaluation form after their last session.
Satisfaction among the participating caregivers was high: 53
(83%) experienced the family meetings as useful, while 8 caregivers
experienced no benefits (data on 3 persons were missing/
inconclusive). The satisfied caregivers attended more family
meetings (difference in mean= 2.3, 95% CI 1.95 to 2.74,
t = 11.75 with 94 df, p = 0.000) and experienced a higher lack of
family support at baseline than the other intervention caregivers
(difference in mean=21.67, 95% CI 23.27 to 20.08, t =22.08
with 93 df, p = 0.040). Also, they cared for persons with dementia
who were more often diagnosed with Alzheimer Disease (66%
versus 44%) and had less ADL dependencies (difference in
mean=20.62, 95% CI 21.21 to 20.04, t =22.13 with 63.5 df,
p = 0.037).
The family meetings lasted on average 73 minutes (range 47–
105). The number of family members/friends attending a meeting
was 4.4 (range 2–14). In 85%, the demented person was not
present at the meetings or only attended a part of the sessions.
Family meetings were organized at the office (57%) or at the
family’s home (43%). The per protocol analyses showed no
significant differences between the adherers and usual care group
on any of the outcome measures (Table 4).
Use of health care and supportive services
For 92/96 caregivers in the usual care group and 89/96
intervention caregivers data on the health care use and supportive
services were available. We found that 52 caregivers in the usual
care group received additional counseling from a psychologist,
case manager or social worker and 51 caregivers in the
intervention group received such counseling (x2 = 0.011, df = 1,
p = 0.915). Twenty caregivers in the usual care group reported
participation in a support group versus 19 caregivers in the
intervention group (x2 = 0.004, df = 1, p= 0.949).
Ancillary analyses
We pre-specified several variables which we assumed as
potential effect modifiers: caring for a more severe demented
patient (MMSE#median of 22) and caregiver gender. Further-
more, we explored whether caregivers having a dementia case
manager (yes/no), caregivers with increased initial depressive
(CES-D$16) or anxious (HADS-A$8) symptoms, and caregivers
with a lack of family support (CRA subscale,median of 12) would
benefit (more) from the intervention. We did not find any evidence
for effect modification.
During the study period, 24 patients were institutionalized, 3
died and 6 died after placement. Sensitivity analyses were carried
out using only caregivers where the patient survived and lived at
home during the entire study. These analyses did not demonstrate
significant effects of family meetings on any of the primary and
secondary outcomes.
Discussion
Interpretation
This study was the first to examine the preventive effects of a
structured family meetings intervention for family caregivers of
dementia patients. The intervention did not prevent the onset of
depression or anxiety disorders, nor reduced symptom levels and
caregiver burden. The incidence of depression and anxiety
disorders was equally substantial in both groups of relatively
young caregivers. Within 12 months, almost 40% of the caregivers
developed a mental disorder according to diagnostic criteria. This
incidence is far higher than in the cohort study of Joling et al
among spouses of dementia patients [3] and than found in
‘general’ elderly cohorts and emphasizes the vulnerability of this
target group [28–30].
Overall evidence
Counseling and support interventions that include family
meetings were investigated by Mittelman et al., who found small
to moderate but significant effects that lasted more than 3 years on
depressive symptomatology in caregivers [16,17]. Subsequently, a
multinational study carried out a similar intervention among
spouses of persons with Alzheimer disease taking donepezil and
also reported a small but significant reduction in depression scores
[31].
The lack of effects in our study may be due to the fact that the
intervention did not include all components of the multi
component NYU Caregiver Intervention. Perhaps the interven-
tion lacked the same time condensed delivery to have an impact on
the outcomes compared to the original protocol in which the
counseling sessions were delivered within 4 months after the intake
assessment, and followed with ad hoc counseling from the same
counselor. However, in the Netherlands, there are many
supportive services available to caregivers and the provided
standard care is already quite intensive in a substantial number
of cases. This relatively high level of usual care may have resulted
in a limited contrast between the intervention and usual care
group and might be a reason for the lack of effects. The non-
significant findings are in accordance with recent meta-analytic
reviews which demonstrated modest evidence for significant effects
of psychosocial interventions [11,12]. Combined intervention
Table 2. Incidence of depressive and anxiety disorders over 12 months follow-up.
Primary endpoint Intervention Usual care IRR* [95% CI] RD# [95% CI]
n (%) n (%)
Depressive- or anxiety disorder 38 (39.5) 34 (35.2) 0.98 [0.69; 1.38] 20.02 [20.16; 0.13]
Depressive disorder 28 (28.8) 19 (20.2) 1.21 [0.80; 1.84] 0.04 [20.08; 0.15]
Anxiety disorder 28 (29.3) 27 (28.5) 0.89 [0.51; 1.56] 20.04 [20.21; 0.14]
IRR: Incidence rate ratio; CI: Confidence interval; RD: Risk difference.
*intervention versus usual care group, adjusted for HADS-A baseline differences and clustering. An IRR.1 means that over a period of 12 months more caregivers in the
intervention group developed a disorder than in the usual care group.
#Risk difference between intervention and usual care group, adjusted for HADS-A baseline differences and clustering.
doi:10.1371/journal.pone.0030936.t002
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programs for both the caregiver and person with dementia were
often effective in delaying long stay care admittance, but to a lesser
extent in improving caregivers’ mental health [32]. The most
successful interventions used a psycho-educational or psychother-
apeutic approach, addressed multiple stressors, were better
adapted to the individual needs of the caregivers and provided a
higher amount and intensity of support [13,33]. Most positive
effects were found in the subgroup of female caregivers and
caregivers caring for people with a dementia diagnosis ‘not
otherwise specified’[34].
The lack of effectiveness in this study may also be due to the fact
that the participants’ compliance with the intervention was not
optimal. Several strategies were taken to maintain a high level of
participation. The sessions were scheduled at the convenience of
the family as much as possible and the counselors provided the
family meetings in the caregivers’ homes if they were unable to
Table 3. Longitudinal changes on continuous outcome measures: depressive symptoms, anxiety symptoms, caregiver burden and
health related quality of life.
Intervention Usual care RxT*
Adjusted mean
[95% CI]
Adjusted mean [95%
CI]
Coefficient
[95% CI]
t-statistic
(df) p-value
Primary endpoints
Depressive symptoms (CES-D) 21.40 [23.91; 1.10] 20.63 (14.0) 0.266
Baseline 11.38 [10.12; 12.64] 11.87 [10.62; 13.12]
6 months 12.42 [11.07; 13.78] 13.00 [11.63; 14.37]
12 months 12.89 [11.10; 14.68] 14.78 [13.29; 16.27]
Anxiety symptoms (HADS-A) 20.55 [21.59; 0.49] 21.05 (13.7) 0.296
Baseline 5.61 [5.12; 6.10] 5.32 [4.84; 5.81]
6 months 5.65 [5.12; 6.18] 5.72 [5.13; 6.31]
12 months 5.52 [4.74; 6.30] 5.78 [5.12; 6.44]
Secondary endpoints
Health related quality of life
(SF-12)
20.75 [24.81; 3.31] 20.37 (14.3) 0.715
Baseline 92.15 [89.38; 94.92] 89.65 [86.87; 92.43]
6 months 91.38 [88.48; 94.27] 89.24 [86.26; 92.21]
12 months 88.71 [84.67; 92.75] 86.96 [83.20; 90.71]
Burden (CRA)
Disrupted time 21.49 [23.01; 0.02] 21.99 (14.1) 0.053
Baseline 15.57 [14.67; 16.47] 15.62 [14.72; 16.53]
6 months 16.21 [15.25; 17.17] 17.24 [16.32; 18.16]
12 months 15.94 [14.71; 17.17] 17.48 [16.34; 18.63]
Financial problems 0.50 [20.28; 1.28) 1.29 (17.9) 0.202
Baseline 6.42 [5.97; 6.87] 6.46 [6.01; 6.91]
6 months 6.50 [6.01; 7.00] 6.81 [6.32; 7.30]
12 months 7.24 [6.38; 8.09] 6.78 [6.03; 7.53]
Lack family support 20.71 [21.92; 0.50] 21.16 (12.7) 0.248
Baseline 13.00 [11.94; 14.07] 12.61 [11.55; 13.67]
6 months 12.95 [11.74; 14.16] 13.69 [12.47; 14.91]
12 months 13.20 [11.88; 14.52] 13.51 [12.13; 14.90]
Health problems 20.40 [21.36; 0.57] 20.81 (18.5) 0.418
Baseline 10.15 [9.53; 10.77] 10.27 [9.66; 10.89]
6 months 10.41 [9.75; 11.07] 10.71 [10.04; 11.38]
12 months 10.83 [10.05; 11.61] 11.35 [10.49; 12.20]
Caregiver’s self-esteem 0.62 [20.56; 1.80] 1.06 (12.8) 0.296
Baseline 27.14 [26.35; 27.94] 26.79 [25.99; 27.59]
6 months 27.33 [26.47; 28.19] 26.43 [25.45; 27.40]
12 months 27.56 [26.51; 28.61] 26.59 [25.60; 27.58]
CES-D: Center for Epidemiologic Studies Depression Scale; HADS-A: Hospital Anxiety and Depression Scales; CRA: Caregiver reaction assessment scale; SF-12: Short Form
12 item version; CI: Confidence interval; R*T: Randomization-by-time interaction.
*The coefficient represents the estimated difference of the scores between the intervention and usual care group over 12 months. Scores were adjusted for HADS-A
baseline differences and estimated with multilevel analysis.
doi:10.1371/journal.pone.0030936.t003
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leave the patients. Nevertheless, about one-quarter of the
intervention caregivers participated in no family meeting at all
and about half of them completed the majority of the sessions.
However, this could also mean that this type of intervention is not
what these relatively young caregivers think that they need.
Another possible explanation for the lack of protective effect in
our study may be that the timing of the intervention was not
appropriate. In contrast with some other studies evaluating family
meetings, we excluded caregivers with major depression or anxiety
at intake to be able to evaluate preventive effects on onset of such a
disorder. Almost 30% had baseline CES-D scores above the cutoff,
indicative of clinically relevant symptoms of depression. This was
lower than the 43% of the caregivers who had scores at baseline
above the cutoff on the Geriatric Depression Scale indicating
possible clinical depression at baseline in the NYU Caregiver
Intervention study. Current research in noncaregiver populations
suggests that prevention is most likely to be effective when
targeting people with increased symptoms levels [8–10]. Indicated
prevention might also be a promising research strategy for the
caregiver population and perhaps family meetings interventions
would be most useful to caregivers with more severe symptom
levels at baseline. Furthermore, a recent study presenting an
overview of successful psychosocial interventions in subgroups of
caregivers of people with dementia, showed that the presence of
mental health problems was frequently related to positive
intervention effects for caregivers [34]. However, evaluation of
possible effect modification by increased initial depressive or
anxiety symptom severity in our study did not show more benefit
of the intervention over usual care.
Unlike the NYU Caregiver Intervention-model, the two
individual and four family counseling sessions were conducted
with a frequency of every 2 to 3 months instead of offering all
sessions in the first four months after enrollment. This might
indicate that, in order to affect change in support for the primary
caregiver, family meetings should be conducted with greater
frequency in a shorter period of time. A pilot with some families
prior to the study was an important reason to choose a larger time
span between the session. Also, from the evaluation forms filled in
by the intervention caregivers who participated in the trial, we
found that most of them were satisfied with the amount of sessions
they received. Perhaps caregivers did prefer a relatively low
frequency, because a majority of them also used other supportive
services. This shows an important dilemma of following the
participant’s preferences on the one hand, and on the other hand
stick to the current evidence that interventions tend to have
stronger effects if they involve more frequent interactions [13,35].
It is also possible that effects might become significant in the
long term. In the NYU Caregiver Intervention study, changes in
depressive symptoms were significant approximately 6 months
after the last counseling session (approximately 10 months after
enrollment). The 12 months follow up period after enrollment in
our study might be too short to detect significant effects, but this is
not very likely in view of the current findings.
According to the random selection of audiotapes that we
listened to, the standardized forms that were completed by the
counselors after each session and the contact between the research
team and counselors during the intervention period, the counselors
mostly carried out the intervention as instructed by the manual
and during the training organized prior to the study. Furthermore,
all counselors were uniformly trained, used a structured manual
and may be assumed to be adequately qualified to lead the family
meetings. Therefore, we might assume that the actual quality of
the intervention was no reason for the lack of effects in our study.
Considering the randomized design, the adjustment for baseline
differences associated with the outcomes, the relatively large
number of subjects, the low drop out rate (from follow-up) and the
adjustment for possible clustering effects, it seems unlikely that the
non-significant results were due to methodological flaws.
Table 4. Per protocol analyses on the primary and secondary outcome measures.
IRR*/R*T
interaction# [95% CI] t-statistic (df) p-value
Primary endpoints
Depressive- or anxiety disorder, IRR 0.89 [0.55; 1.44] 0.632
Depressive disorder, IRR 1.10 [0.61; 1.97] 0.755
Anxiety disorder, IRR 0.87 [0.48; 1.57] 0.647
Depressive symptoms (CES-D), R*T 21.30 [23.91; 1.30] 20.99 (62.8) 0.325
Anxiety symptoms (HADS-A), R*T 20.52 [21.74; 0.70] 20.84 (14.2) 0.400
Secondary endpoints
Health related quality of life (SF-12) , R*T 0.11 [24.48; 4.69] 0.05 (24.5) 0.963
Burden (CRA), R*T
Disrupted time 21.24 [22.99; 0.52] 21.41 (17.5) 0.165
Financial problems 0.29 [20.65; 1.24] 0.62 (17.0) 0.538
Lack family support 20.88 [22.44; 0.67] 21.13 (16.9) 0.262
Health problems 20.38 [21.67; 0.91] 20.59 (15.6) 0.554
Caregiver’s self-esteem 0.14 [21.17; 1.45] 0.21 (15.7) 0.834
IRR: Incidence rate ratio; CI: Confidence interval; CES-D: Center for Epidemiologic Studies Depression Scale; HADS-A: Hospital Anxiety and Depression Scales; CRA:
Caregiver reaction assessment scale; SF-12 Short Form 12 item version; CI: Confidence interval; R*T: Randomization-by-time interaction.
*intervention versus usual care group, adjusted for HADS-A baseline differences and clustering. An IRR.1 means that over a period of 12 months more caregivers in the
intervention group developed a disorder than in the usual care group.
#The randomization-by-time interaction coefficient represents the estimated difference of the scores between the intervention and usual care group over 12 months.
Scores were adjusted for HADS-A baseline differences and estimated with multilevel analysis.
doi:10.1371/journal.pone.0030936.t004
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Generalisability
We performed a randomized controlled trial with only a few
exclusion criteria. A substantial number of caregivers invited for
the study were not willing to participate, mainly due to a lack of
perceived need for this intervention. Although this limits the
feasibility of this intervention for many caregivers, the results
reflect the effectiveness in usual routine care for caregivers who
were interested in this intervention. Caregivers in our sample were
predominantly women caring for a –relatively young- demented
spouse, while according to population based studies about half of
the demented patients in this age group are women [36,37]. A care
setting based study like our study starts with people who asked for
care or a diagnostic assessment and therefore the gender
distribution could differ from the one reported in population
based studies. Participants in our study did not differ significantly
from the persons who declined participation with regard to
gender, patient-carer relation, and the service they were
recruitment from, and therefore, our sample seems to be
representative for the population that receives treatment or
diagnostic assessment at these services.
Conclusions
This study did not show any preventive effects of family
meetings compared with usual care. The substantial number of
invited caregivers unwilling to participate and poor intervention
uptake indicates that family meetings are only acceptable for some
of the caregiver population. This also reflects the diversity among
caregivers in their need for different types and intensity of support.
Although this intervention could not prevent caregivers from
developing depression and anxiety, certain family caregivers may
feel supported and satisfied about this intervention. Although,
from our results no subgroups emerge for whom the intervention
could work for, it can be hypothesized that caregivers with certain
characteristics we did not take into account (like coping style)
might benefit more from family meetings. The finding that
caregivers were more satisfied about the family meetings when
experiencing a higher lack of family support prior to the
intervention might indicate that family meetings better fulfill the
needs of the caregiver when a certain lack of family support is
experienced.
Researchers might consider studying the effects of organizing
family meetings for specific subgroups of caregivers or with a
therapeutic purpose. Further research should determine whether
family meetings alone, might then be more beneficial if delivered
more intensively over a shorter period of time or whether the
intervention’s effectiveness may be derived from its multicompo-
nent nature. Other studies should be conducted to evaluate the
transportability of evidence-based interventions such as the
NYUCI to cultures in which usual care provide substantial
support for family caregivers.
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